Benign prostatic hyperplasia: US-guided transrectal urethral enlargement with radio frequency - Initial results in a canine model

Radiology

Volumn 208, Issue 2, 1998, Pages 491-498

  Goldberg, S Nahum ^a   Hahn, Peter F ^a   McGovern, Francis J ^a   Fogle, Robert M ^a   Mueller, Peter R ^a   Gazelle, G Scott ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Prostate, hyperplasia; Prostate, therapeutic radiology; Prostate, US; Radiofrequency (RF) ablation

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATHETER ABLATION; CONTROLLED STUDY; DOG; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RADIOFREQUENCY; RECTUM MUCOSA; THERMOCOAGULATION; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL RESECTION;

EID: 0031855706     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.208.2.9680581     Document Type: Article

References (25)

1. Oesterling JE. Benign prostatic hyperplasia: medical and minimally invasive treatment options. N Engl J Med 1995; 332:99-109.
2. Graversen PH, Gasser TC, Wasson JH, Hinman F Jr, Bruskewitz RC. Controversies about indications for transurethral resection of the prostate. J Urol 1989; 141:475-481.
3. Roth RA, Aretz HT. Transurethral ultrasound-guided laser-induced prostatectomy (TULIP procedure): a canine prostate feasibility study. J Urol 1991; 146:1128-1135.
4. McCullough DL, Roth RA, Babayan RK, et al. Transurethral ultrasound-guided laser-induced prostatectomy: national human cooperative study results. J Urol 1993; 150:1607-1611.
5. Harada T, Etori K, Kumazaki T, Nishizawa O, Noto H, Tsuchida S. Microwave surgical treatment of diseases of the prostate. Urology 1985; 26:572-576.
6. Ogden CW, Reddy P, Johnson H, Ramsay JW, Carter SS. Sham versus transurethral microwave thermotherapy in patients with symptoms of benign prostatic bladder outflow obstruction. Lancet 1993; 341: 14-17.
7. Goldwasser B, Ramon J, Engelberg S, et al. Transurethral needle ablation (TUNA) of the prostate using low-level radiofrequency energy: an animal experimental study. Eur Urol 1993; 24:400-405.
8. Viguier JL, Dessouki T, Castelo A, et al. Benign prostatic hypertrophy treatment by transurethral radiofrequency hyperthermia with Thermex II. Eur Urol 1993; 23:318-321.
9. Zlotta AR, Peny MO, Matos C, Schulman CC. Transurethral needle ablation of the prostate: clinical experience in patients in urinary acute retention. Br J Urol 1996; 77:391-397.
10. Issa MM. Transurethral needle ablation of the prostate: report of initial United States clinical trial. J Urol 1996; 156:413-419:
11. Mostafid AH, Harrison NW, Dawkins GP, Fletcher MS. Interstitial radiofrequency therapy of the prostate: results of a pilot study. J Urol 1996; 155:1946-1948.
12. Ramon J, Goldwasser B, Shenfeld O, Engelberg S, Rasor JS, Edwards SD. Needle ablation using radio frequency current as a treatment for benign prostatic hyperplasia: experimental results in ex vivo human prostate. Eur Urol 1993; 24:406-410.
13. Schulman CC, Zlotta AR, Rasor JS, Mourriez L, Noel JC, Edwards SD. Transurethral needle ablation: safety, feasibility, and tolerance of a new office procedure for treatment of benign prostatic hyperplasia. Eur Urol 1993; 24:415-423.
14. McGahan JP, Griffey SM, Budenz RW, Brock JM. Percutaneous ultrasound-guided radiofrequency electrocautery ablation of prostate tissue in dogs. Acad Radiol 1995; 2:61-66.
15. Cosman ER, Nashold BS, Ovelman-Levitt J. Theoretical aspects of radiofrequency lesions in the dorsal root entry zone. Neurosurgery 1984; 15:945-950.
16. Rosenthal DI, Springfield DS, Gebhart MC, Rosenberg AE, Mankin HJ. Osteoid osteoma: percutaneous radiofrequency ablation. Radiology 1995; 197:451-454.
17. Anzai Y, Lufkin R, DeSalles A, Hamilton DR, Farahani K, Black KL. Preliminary experience with MR-guided thermal ablation of brain tumors. AJNR 1995; 16: 39-48.
18. Rossi S, DiStasi M, Buscarini E, et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR 1996; 167:759-768.
19. Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided RF tissue ablation of liver metastases: long-term follow up. Radiology 1997; 202:195-203.
20. Livraghi T, Goldberg SN, Monti F, et al. Saline-enhanced radiofrequency tissue ablation in the treatment of liver metastases. Radiology 1997; 202:205-210.
21. Solbiati L, Goldberg SN, Ierace T, Livraghi T, Sironi S, Gazelle GS. Hepatic metastases: radiofrequency ablation with cooled-tip electrodes. Radiology 1997; 205:367-374.
22. McGahan JP, Brock JN, Tessluk H, Wei-Zhong G, Schneider P, Browning PD. Hepatic ablation with use of radiofrequency electrocautery in the animal model. JVIR 1992; 3:291-297.
23. Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with radiofrequency: effect of probe size, gauge, duration and temperature on lesion volume. Acad Radiol 1995; 2:399-404.
24. Goldberg SN, Gazelle GS, Solbiati L, Rittman WJ, Mueller PR. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol 1996; 3:636-644.
25. Clements R, Aideyau OU, Griffiths GJ, Peeling WB. Side effects and patient acceptance of transrectal biopsy of the prostate. Clin Radiol 1993; 47:125-126.